136 related articles for article (PubMed ID: 24316906)
21. SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors.
Li Z; Yuan J; Wei L; Zhou L; Mei K; Yue J; Gao H; Zhang M; Jia L; Kang Q; Huang X; Cao D
Int J Clin Exp Pathol; 2015; 8(6):7072-82. PubMed ID: 26261600
[TBL] [Abstract][Full Text] [Related]
22. SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 Tumors.
Dum D; Kromm D; Lennartz M; De Wispelaere N; Büscheck F; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Minner S; Krech R; Bernreuther C; Marx A; Steurer S; Jacobsen F; Clauditz T; Krech T
Arch Pathol Lab Med; 2023 Apr; 147(4):451-464. PubMed ID: 35917493
[TBL] [Abstract][Full Text] [Related]
23. [Diagnostic value of SATB2, CK7 and CK20 in colorectal cancer].
Lyn J; Wang Y; Wang F; Shen M; Zhou X
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):578-81. PubMed ID: 26705182
[TBL] [Abstract][Full Text] [Related]
24. SATB2 Versus CDX2: A Battle Royale for Diagnostic Supremacy in Mucinous Tumors.
Brettfeld SM; Ramos BD; Berry RS; Martin DR; Hanson JA
Arch Pathol Lab Med; 2019 Sep; 143(9):1119-1125. PubMed ID: 30838879
[TBL] [Abstract][Full Text] [Related]
25. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.
Bellizzi AM
Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624
[TBL] [Abstract][Full Text] [Related]
26. SATB2 Is Superior to CDX2 in Distinguishing Signet Ring Cell Carcinoma of the Upper Gastrointestinal Tract and Lower Gastrointestinal Tract.
Ma C; Lowenthal BM; Pai RK
Am J Surg Pathol; 2018 Dec; 42(12):1715-1722. PubMed ID: 30212392
[TBL] [Abstract][Full Text] [Related]
27. Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas.
Kim CJ; Baruch-Oren T; Lin F; Fan XS; Yang XJ; Wang HL
J Clin Pathol; 2016 Dec; 69(12):1046-1050. PubMed ID: 27169755
[TBL] [Abstract][Full Text] [Related]
28. SATB1 and 2 in colorectal cancer.
Brocato J; Costa M
Carcinogenesis; 2015 Feb; 36(2):186-91. PubMed ID: 25543122
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous Osteoblastic Osteosarcoma: Report of 2 New Cases Integrated With SATB2 Immunohistochemistry and Review of the Literature.
Falconieri G; Cataldi P; Kavalar R; Štitič V; Luzar B
Am J Dermatopathol; 2016 Nov; 38(11):824-831. PubMed ID: 27043339
[TBL] [Abstract][Full Text] [Related]
30. Loss of SATB2 Expression Is a Biomarker of Inflammatory Bowel Disease-associated Colorectal Dysplasia and Adenocarcinoma.
Ma C; Henn P; Miller C; Herbst C; Hartman DJ; Pai RK
Am J Surg Pathol; 2019 Oct; 43(10):1314-1322. PubMed ID: 31318711
[TBL] [Abstract][Full Text] [Related]
31. [Value of MDM2, CDK4 and SATB2 immunohistochemistry in histologic diagnosis of low-grade osteosarcoma].
Chen CY; Zhang HZ; Jiang ZM; Zhou J; Chen J; Liu L
Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):387-92. PubMed ID: 27256046
[TBL] [Abstract][Full Text] [Related]
32. Dual Immunostain With SATB2 and CK20 Differentiates Appendiceal Mucinous Neoplasms From Ovarian Mucinous Neoplasms.
Li Z; Roth R; Rock JB; Lehman A; Marsh WL; Suarez A; Frankel WL
Am J Clin Pathol; 2017 May; 147(5):484-491. PubMed ID: 28340228
[TBL] [Abstract][Full Text] [Related]
33. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation.
Dobreva G; Chahrour M; Dautzenberg M; Chirivella L; Kanzler B; Fariñas I; Karsenty G; Grosschedl R
Cell; 2006 Jun; 125(5):971-86. PubMed ID: 16751105
[TBL] [Abstract][Full Text] [Related]
34. SOX9 and SATB2 immunohistochemistry cannot reliably distinguish between osteosarcoma and chondrosarcoma on biopsy material.
Sharma AE; Pytel P; Cipriani NA
Hum Pathol; 2022 Mar; 121():56-64. PubMed ID: 35016891
[TBL] [Abstract][Full Text] [Related]
35. Maternal regulation of SATB2 in osteo-progeniters impairs skeletal development in offspring.
Chen JR; Zhao H; Lazarenko OP; Blackburn ML; Shankar K
FASEB J; 2020 Feb; 34(2):2511-2523. PubMed ID: 31908011
[TBL] [Abstract][Full Text] [Related]
36. Sclerosing epithelioid fibrosarcoma of the thigh: report of two cases with synchronous bone metastases.
Righi A; Gambarotti M; Manfrini M; Benini S; Gamberi G; Cocchi S; Casadei R; Picci P; Vanel D; Dei Tos AP
Virchows Arch; 2015 Sep; 467(3):339-44. PubMed ID: 26209924
[TBL] [Abstract][Full Text] [Related]
37. Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue-specific manner and demonstrates cell-type-dependent expression in the developing mouse CNS.
Britanova O; Akopov S; Lukyanov S; Gruss P; Tarabykin V
Eur J Neurosci; 2005 Feb; 21(3):658-68. PubMed ID: 15733084
[TBL] [Abstract][Full Text] [Related]
38. CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors.
Chiesa-Vottero A
Int J Gynecol Pathol; 2020 Mar; 39(2):170-177. PubMed ID: 32045390
[TBL] [Abstract][Full Text] [Related]
39. SATB2 participates in regulation of menadione-induced apoptotic insults to osteoblasts.
Wei JD; Lin YL; Tsai CH; Shieh HS; Lin PI; Ho WP; Chen RM
J Orthop Res; 2012 Jul; 30(7):1058-66. PubMed ID: 22570222
[TBL] [Abstract][Full Text] [Related]
40. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours: comment on Conner et al. (2013).
Creytens D; Ferdinande L
Histopathology; 2015 Aug; 67(2):272-3. PubMed ID: 25469978
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
